LIGHTPATH TECHNOLOGIES INC (LPTH) stock intrinsic value fair value estimate & owner earnings analysis

LightPath Technologies makes optics and infrared imaging products. Its Orlando plant moulds precision glass lenses and produces its own BlackDiamond chalcogenide glass, an infrared material that substitutes for germanium. A plant in Riga, Latvia makes infrared optics. Visimid in Plano, Texas adds thermal camera cores, G5 Infrared in Hudson, New Hampshire builds cooled long-range infrared camera systems for counter-drone, naval and border-security programmes, and Amorphous Materials in Garland, Texas, bought in January 2026, adds the AMTIR line of infrared glasses. With germanium supply concentrated in China and Russia and subject to export restrictions, LightPath's own glass is the strategic heart of the company. What changed since our last look. The year to June 2026 is now complete and audited. Revenue nearly doubled to $71.7 million from $37.2 million and gross margin rose to 36 percent from 27 percent. Backlog at June 2026 was $110.9 million, of which $85.6 million is scheduled for delivery within a year; about $58 million of it is a single order from a large global technology customer for infrared camera systems shipping through calendar 2027. That one customer was already 24 percent of the year's sales. The company also sold about $112 million of new shares, so it now holds $93.2 million of cash with almost no borrowings, against $4.9 million a year earlier. In April 2026 the final G5 earnout was fixed at $9 million ($6.3 million cash, $2.7 million in shares) payable in January 2027, removing that uncertainty. In July 2026 LightPath agreed to sell its Zhenjiang, China plant to a company owned by local managers for $4.5 million paid over up to five years, with the plant continuing to supply LightPath at cost plus ten percent. Together these remove the funding risk that dominated our previous downside case, which is the main reason the low end rose; the higher case values fall because the share count grew from about 59 million to roughly 76 million on a fully diluted basis, and because we no longer credit growth that is not yet won. What the business earns. We measure the cash the business produces for its owners after the working capital it ties up, stock compensation and the capital spending needed to keep the plants running. On that measure LightPath has not earned anything for its owners in any year since fiscal 2018: the shortfall ran from $0.7 million in 2022 to $8.3 million in 2025, and in fiscal 2026 it narrowed to about $3.5 million, or about 7 cents a share. Two accounting judgements matter. First, the reported loss of $20.5 million includes a $15.6 million non-cash charge for the rising value of earnouts owed to the sellers of G5 and Amorphous Materials; we add it back, and treat the earnouts instead as debts owed. Second, $3.8 million of cash paid to G5's sellers was recorded within operating cash flow; it is purchase price, not a cost of running the business, so we excluded it. About $9.6 million of cash went into receivables, inventory and prepayments to support the larger order book; we treat that as investment in growth rather than lost earnings. Amortisation of acquired intangibles, about $1.8 million a year, is added back as sunk purchase cost, and the decay of those acquired customer relationships is reflected in the cases rather than in the earnings level. Ten years of cash flow statements reconcile exactly. Because there is no year of positive owner earnings in the business as it exists today, there is no earnings level to anchor on. The cases are therefore built from what is in hand: the backlog, the cash, and the gross margin already achieved, and nothing that has not been won. Interest income on the cash pile is excluded from the business cash flows because the cash itself is counted separately. Base case. The $85.6 million of near-term backlog ships, gross margin holds in the mid-30s and overheads, which were $28.4 million in fiscal 2026, rise only modestly, so the business produces about $3 million of owner cash in fiscal 2027 and about $2 million in fiscal 2028. After the large camera order is delivered, revenue settles where recurring defence and industrial demand takes it and the business earns about $1.5 million a year through 2036, fading to about $1 million beyond as acquired relationships decay. We did not credit further revenue growth: the company has never shown it can grow while generating cash, and new design wins for BlackDiamond at defence primes are hoped for, not contracted. The business on this path is worth about $17 million. Add roughly $74 million of net cash (the $93.2 million balance less about $10 million of working cash the business needs, the $6.3 million cash earnout, the $1.4 million Amorphous Materials earnout and $0.9 million of loans and finance leases, plus about $4 million for the China sale proceeds), and the shares are worth about $1.19 each on about 76.3 million diluted shares, which counts the Series G preferred as converted at $2.15. Bear case. The $58 million order is a one-off and is not repeated; one customer at 24 percent of sales is a concentration the filings flag. Defence procurement has demonstrably cycled, and in the bear case a programme pause like the 2013 sequestration hits orders for two to three years. Overheads built for a $70 million business do not shrink, and the business loses $3 to $5 million a year from fiscal 2028 to 2032 before recovering to break-even. That consumes about $17 million of value. Add the $74 million of net cash and the shares are worth about $0.75. This case also captures the company's own record: acquisitions have repeatedly added revenue without adding owner earnings. Bull case. Backlog converts on schedule, the large customer reorders on similar terms, and gross margin moves to the 40 percent level that in-house BlackDiamond glass makes possible as purchased germanium is designed out of G5's cameras, a substitution the company has already done on two models. Owner cash rises to about $8 million a year by fiscal 2030 and holds, fading to $6 million beyond 2036. The business is worth about $77 million, and with net cash the shares are worth about $1.98. What each case owes. The company has almost no debt: about $0.2 million of loans and $0.7 million of finance leases. Its real obligations are the $9 million G5 earnout due January 2027 and the $1.4 million Amorphous Materials earnout. In every case cash exceeds what the company owes by a wide margin, and no maturity or covenant affects the outcome. Margin of safety price. How sure are we of the earnings level? Not sure at all: this business has not produced owner cash in eight years, and fiscal 2026 was still negative. What we are sure of is the cash: about $0.97 a share after the earnouts and working needs. The worst plausible outcome is not insolvency, which the balance sheet now rules out, but a slow burn of that cash on overheads and on further acquisitions paid with new shares, which is exactly what the company has done over the past decade; the Series G preferred, warrants and option pool add further dilution. If we are wrong about the camera order repeating and about overheads staying flat, the value sits near the bear case. The business pays no dividend, so nothing is paid out over the holding period, and every year of losses erodes the cash. The margin-of-safety price is $0.80 a share. That price is less than the net cash, assigns no value to the operating business, the BlackDiamond glass franchise or the $110.9 million backlog, and sits above the bear-case value only modestly; reaching the base case value within about a year and a half, or the bull case within three to four years, would imply the return target. Above that price the estimate depends on an earnings record the company does not have.